Medtronic said that a Delaware jury has rendered verdicts in patent litigation between Medtronic and the ACS subsidiary of Guidant. The jury found that the Guidant Lau patents at issue are valid and that certain Medtronic stents (including the S7 and Driver stents), infringe those patents, according to Minneapolis-based Medtronic.
The jury verdict wraps up the jury phase of the trial, but does not conclude the court proceeding, Medtronic said. A further hearing regarding Medtronic's claim that Guidant's patent is unenforceable due to "inequitable conduct' will be held by the U.S. District Court for the District of Delaware at a yet-to-be-determined date.
The outcome of that hearing will conclude the evidence phase of the trial, and could impact the jury verdicts, according to Medtronic. In the meantime, the jury verdicts do not inhibit Medtronic from selling its coronary stents in the U.S., Medtronic said.
By AuntMinnie.com staff writersFebruary 21, 2005
Related Reading
Medtronic infringement ruling reversed, February 3, 2005
Court issues judgment in stent patent dispute, January 6, 2005
Medtronic receives FDA OK for stent clinical trial, February 12, 2004
Medtronic stent receives FDA OK, October 2, 2003
Butel named Medtronic VP, August 21, 2003
Copyright © 2005 AuntMinnie.com
